Moderna tests mRNA vaccines for four viruses in one study

NCT ID NCT05397223

Completed ⭐️ VACCINE ⭐️ Sponsor: ModernaTX, Inc. Source: ClinicalTrials.gov ↗

First seen Apr 02, 2026 · Last updated May 25, 2026 · Updated 5 times

Summary

This study tested the safety and immune response of several modified mRNA vaccines in 308 healthy adults aged 18 to 75. The vaccines target SARS-CoV-2, seasonal influenza, respiratory syncytial virus, and cytomegalovirus. Researchers monitored side effects and measured antibody levels to see how well the vaccines work.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARS-COV-2 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Benchmark Research

Austin, Texas, 78705, United States
CenExel

Hollywood, Florida, 33024, United States
DM Clinical Research- Texas Center for Drug Development

Houston, Texas, 77081, United States
Johnson County Clinical Trials

Lenexa, Kansas, 66219, United States
Meridian Clinical Research

Savannah, Georgia, 31406, United States
Meridian Clinical Research

Sioux City, Iowa, 51106, United States
Meridian Clinical Research

Lincoln, Nebraska, 68510, United States
Tekton Research, Inc

Austin, Texas, 78745, United States

Conditions

Explore the condition pages connected to this study.

CYTOMEGALOVIRUS RESPIRATORY SYNCYTIAL VIRUS SARS-COV-2 SEASONAL INFLUENZA